Ethical Naturals Inc. (ENI), San Anselmo, CA, a supplier of botanical ingredients to the U.S. and International supplement, beverage, and food markets, along with KGK Synergize (Canada), has completed a randomized, double-blind, placebo-controlled clinical study which investigated the effect of ENI’s patented whole grape extract on cholesterol and antioxidant status. The study included 26 human subjects exhibiting symptoms associated with one or more of the following conditions: pre-hypertension, overweight, and/or pre-diabetes. The outcome of this study demonstrated that Ethical Naturals’ whole grape extract has a positive effect on increasing HDL-C, and decreasing total cholesterol/HDL-C ratios in subjects after supplementation for 6 weeks. Key biomarkers reflecting oxidative stress, such as 8-isoprostane levels, were also improved in subjects using ENI’s patented whole grape extract versus the placebo group. The extract was found to be safe and well tolerated at a dose of 350mg/day in the population studied.
For further information: www.ethicalnaturals.com